FGF/FGFR1,2 targeting can attenuate lung parenchymal and vascular remodeling: an opportunity for drug repurposing against chronic lung disease and post COVID‐19 sequelae.
Saved in:
| Title: | FGF/FGFR1,2 targeting can attenuate lung parenchymal and vascular remodeling: an opportunity for drug repurposing against chronic lung disease and post COVID‐19 sequelae. |
|---|---|
| Authors: | Kulshrestha, R.1 (AUTHOR) ritukumar71@yahoo.com, Rani, M.1 (AUTHOR), Dahiya, R.1 (AUTHOR), Singh, A.1 (AUTHOR), Doraiswamy, S.1 (AUTHOR), Bharadwaj, S.1 (AUTHOR), Batra, J.2 (AUTHOR), Kumar, P.1 (AUTHOR), Pandey, A.1 (AUTHOR), Dinda, A. K.3 (AUTHOR), Krishnan, R.4 (AUTHOR), Mishra, A. K.5 (AUTHOR) |
| Source: | Surgical & Experimental Pathology. 9/20/2025, Vol. 8 Issue 1, p1-18. 18p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
